CSTA and myeloid sarcoma: They found mono- and di-oxidized cystatin SN, mono- and di-oxidized cystatin S1, cystatin SA and mono-oxidized cystatin SA, mono-phosphorylated statherin levels to be lower, while antileukoproteinase, two proteoforms of prolactin-inducible protein, three proteoforms of P-C peptide, the SV1 fragment of statherin, two cystatin SN variants and a cystatin A variant to differentiate between MS patients and controls [140].